

NPS Pharmaceuticals to Present at Upcoming Health Care Conferences
BEDMINSTER, N.J.--([ BUSINESS WIRE ])--NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) will present at the Citi 2011 Global Health Care Conference in New York on Tuesday, March 1, 2011 at 10:30 a.m. ET and the Cowen and Company 31st Annual Health Care Conference in Boston on Monday, March 7, 2011 at 2:30 PM ET. Presentations will be available as live webcasts with replays available approximately three hours after the presentation has concluded. Interested parties may access the webcasts from the investorsa™ calendar of events page on the NPS website at [ http://www.npsp.com/events ].
About NPS Pharmaceuticals
NPS Pharmaceuticals is an outsourcing-based development company focused on bringing biopharmaceuticals to patients with rare disorders and few, if any, therapeutic options. The company is advancing two Phase 3 registration programs, GATTEX® (teduglutide) in short bowel syndrome (SBS) and NPSP558 (parathyroid hormone 1-84 [rDNA origin] injection) in hypoparathyroidism. NPS complements its proprietary programs with a royalty-based portfolio of products and product candidates that includes agreements with Amgen, Kyowa Hakko Kirin, Nycomed, and Ortho-McNeil Pharmaceutical.